Variables | Controls (n = 26) (%) | NO DR (n = 26) (%) | NPDR (n = 29) (%) | PDR (n = 26) (%) | F/χ2 value | p value |
---|---|---|---|---|---|---|
Age (yrs) | 60.45 ± 1.43 | 60 ± 1.54 | 58.33 ± 2.32 | 63.89 ± 1.95 | 1.58 | 0.265 |
Sex | ||||||
 Female | 10 (36.4) | 11 (40.9) | 9 (28.0) | 7 (22.7) | 2.20 | 0.587 |
 Male | 16 (63.6) | 15 (59.1) | 20 (72.0) | 19 (77.3) |  |  |
HbA1c (%) | 5.41 ± 0.12 | 7.94 ± 0.21 | 8.50 ± 0.295 | 8.84 ± 0.167 | 55.87 | <0.001 |
S. urea (mg/dl) | 33.278 ± 0.854 | 38.078 ± 2.154 | 37.87 ± 0.978 | 39.84 ± 1.13 | 4.31 | 0.008 |
S. creatinine (mg/dl) | 0.98 ± 0.02 | 1.16 ± 0.03 | 1.15 ± 0.03 | 1.64 ± 0.07 | 46.546 | <0.001 |
VA (LogMAR) | 0.089 ± 0.02 | 0.36 ± 0.14 | 0.76 ± 0.07 | 1.16 ± 0.02 | 109.76 | <0.001 |
CST (μm) | 246.91 ± 2.62 | 267.73 ± 4.37 | 308.72 ± 22.52 | 456.91 ± 19.36 | 37.21 | <0.001 |
CAT (μm) | 255.67 ± 1.08 | 273.44 ± 7.57 | 301.06 ± 9.37 | 371.26 ± 6.23 | 50.675 | <0.001 |
RNFL (μm) | 89.38 ± 0.33 | 85.57 ± 0.89 | 86.06 ± 0.92 | 72.35 ± 1.37 | 61.14 | <0.001 |
EZ | ||||||
 Disruption absent | 26 (100.0) | 23 (95.5) | 24 (56.0) | 0 (0.0) | 60.66 | <0.001 |
 Disruption present | 0 (0.0) | 3 (4.5) | 5 (44.0) | 26 (100.0) |  |  |
RI-CRA | 0.66 ± 0.01 | 0.77 ± 0.01 | 0.79 ± 0.02 | 0.987 ± 0.09 | 10.24 | <0.001 |